More Clever Culture Systems Limited news
Clever Culture Systems LimitedASX: CC5

US FDA 510(k) Submission for MRSA Analysis Module

Mar 29, 2020 at 11:00 PM EDT · Issued by Clever Culture Systems Limited

Filed with ASX · Mar 29, 2020 at 11:00 PM EDT

On 6ix: 6ix.com/news/us-fda-510k-submission-for-mrsa-analysis-module

Clever Culture Systems Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Clever Culture Systems Limited on 6ix

Story so far

  • MRSA Analysis Module CE Mark RegistrationSep 25, 2019
  • MRSA Analysis Module - Clinical Study CommencedApr 2, 2019

Earlier from Clever Culture Systems

  • VRE Analysis Module - Clinical Study CommencedMar 19, 2020
  • Johns Hopkins Hosp to Present Study Data APAS IndependenceMar 11, 2020
  • LBT Receives $1.1 Million R&D Tax IncentiveJan 21, 2020
  • Presentation at Biotech Showcase Investor ConferenceJan 13, 2020
  • CEO Presentation - AGM 2019Nov 27, 2019

Later from Clever Culture Systems

  • Presentation at NWR Virtual Small Cap ConferenceApr 29, 2020
  • South Australian Government Agree to Extend Loan FacilityMay 7, 2020
  • $1.5M Draw Down on South Australian Government LoanMay 25, 2020
  • Update on MRSA Analysis Module US FDA SubmissionJun 3, 2020
  • First Sale of APAS Independence in United StatesJun 8, 2020
All Clever Culture Systems news releases↗

Follow Clever Culture Systems into a list and get an email when it puts out news.

Follow Clever Culture Systems
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer